p27
kip1 is a general inhibitor of Cdks that preferentially accumulates and functions during G1 phase, before the restriction point of the mammalian cell cycle. We observed that injection of puri®ed p27 kip1 into Xenopus oocytes potently inhibits the G2/M transition and activation/dephosphorylation of the maturation promoting factor (MPF, p34 cdc2 /cyclin B complex) kinase associated with germinal vesicle breakdown (GVBD) induced by progesterone or insulin. Addition of exogenous p27 kip1 in vitro to lysates of hormonally matured oocytes blocked the enzymatic activity of the activated MPF kinase present in those extracts. Interestingly, the isolated amino-terminal region of p27 kip1 (p27N), encompassing only the Cdk binding site, exhibited a similar inhibitory behavior in vitro and a weaker inhibitory eect in vivo than the complete p27 kip1 protein. Surprisingly, the remaining carboxy-terminal region of p27 kip1 (p27C) actually induced GVBD when injected alone into the oocytes, and also accelerated the kinetics of insulin-or progesterone-induced GVBD. Consistent with the in vivo observations, p27C formed a complex with, and activated, the MPF kinase in lysates of immature oocytes, although this activation was blocked by simultaneous addition of p27N or complete p27 kip1 . Active MPF was able to phosphorylate p27C only in the absence of p27N or whole p27 kip1 , suggesting that the inhibitory activity associated with the amino terminus is dominant over the activation produced by p27C. These results demonstrate the functional interaction of p27 kip1 with cyclin B/p34 cdc2 complexes during G2/M progression in oocytes, and suggest that the amino and carboxy terminal portions of this protein may play opposite regulatory roles, reminiscent of the corresponding N-and C-terminal portions of p21
Introduction
Progression through the cell cycle in higher eukaryotes is controlled through formation and activation of complexes between cyclins and cyclin dependent kinases (Cdks) . The ®rst such complex identi®ed, composed of p34 cdc2 and B-type cyclins, acts at the G2/M phase, mediating entry in mitosis or meiosis in eukaryotic cells (Moreno et al., 1989; Nurse, 1990) . Cdk2, a kinase closely related to p34 cdc2 (Elledge and Spottswood, 1991; Paris et al., 1991) , associates with A, D and E cyclins at the G1 and S phases of the mammalian cell cycle (Fang and Newport, 1991; Ko et al., 1991; Rosenblatt et al., 1992; Pagano et al., 1993) . Activity of Cdk complexes is regulated by phosphorylation and dephosphorylation of speci®c tyrosine and threonine residues (Norbury et al., 1991; Solomon et al., 1992 Solomon et al., , 1993 Draetta, 1993; Coleman and Dunphy, 1994) , as well as by interaction with the negative regulators (CDIs) including members of the Ink4 (Guan et al., 1994; Hannon and Beach, 1994; Chan et al., 1995; Hirai et al., 1995) and the p21 waf / p27 kip1 (Toyoshima and Hunter, 1994; Harper et al., 1995; Lee et al., 1995) families. p27 kip1 was discovered as a relatively abundant factor that blocked cyclin E/Cdk2 activity during G1 phase in TGFb-and cell-cell contact arrested cultures (Polyak et al., 1994a) . In vitro experiments have shown that p27 kip1 potently inhibits Cdk2 and Cdk4 activities through a binding site in the amino-terminus of this protein (Polyak et al., 1994b; Toyoshima and Hunter, 1994; Russo et al., 1996) which also interacts with the cyclin partner in the complex (Chen et al., 1996; Russo et al., 1996) . The structure/function of the carboxy-terminal half of p27 kip1 is less de®ned; it contains a potential nuclear localization signal and a potential p34 cdc2 phosphorylation site near the extreme C-terminus (Polyak et al., 1994b; Toyoshima and Hunter, 1994) . In vivo association of p27 kip1 with Cdk4 and Cdk2 has been reported (Poon et al., 1995) , suggesting that the inhibitory eect of p27 kip1 is physiological. Consistent with an in vivo regulatory role, immunodepletion of p27 kip1 from lysates of G1-arrested macrophages by cAMP restores Cdk4 activation (Kato et al., 1994) . The crystal structure of the p27 inhibitory domain (amino-terminal portion, p27N) complexed with cyclin A/Cdk2 has been resolved (Russo et al., 1996) , revealing insights in the mechanism of inhibition. Although no association with p34 cdc2 has been observed, p27 kip1 blocks p34 cdc2 activity in vitro, but to a lesser extent than the inhibition exerted on Cdk2 and Cdk4 (Toyoshima and Hunter, 1994) . However, no inhibition of p34 cdc2 kinase activity by p27 kip1 has yet been reported in vivo.
To study in detail the biological properties of p27 kip1 , as well as the structure-function relationship of its amino-and carboxy-terminal domains, we injected recombinant p27 kip1 and derived fragments into fullygrown, stage VI, Xenopus laevis oocytes. Xenopus oocytes are arrested at the G2/M boundary of the ®rst meiotic division and are able to progress through this blockade by hormonal activation of the MPF (maturation promoting factor) kinase complex, formed by cyclin B and p34 cdc2 . Immature oocytes contain signi®cant amounts of inactive cyclin B/p34 cdc2 (prematuration promoting factor; pre-MPF) in which cdc2 is phosphorylated in tyrosine Y15 and threonines T14 and T161 (Krek and Nigg, 1991; Loundgren et al., 1991; Norbury et al., 1991; Parker et al., 1992; McGowen and Russell, 1993) . Whereas T14 and Y15 are dominant inhibitory phosphorylations of p34 cdc2 activity, T161 is essential for the kinase activity (Millar et al., 1991) . Activation of MPF by cdc25 phosphatase (Gautier et al., 1991) leads to meiotic maturation, i.e. germinal vesicle breakdown (GVBD). Xenopus oocytes possess at least two independent pathways for regulating GVBD. In one, progesterone treatment decreases adenylate cyclase activity, with a resulting drop in overall cAMP levels and PKAdependent phosphorylations. In the other pathway, insulin or IGF-1 triggers a cascade of phosphorylations initiated by tyrosine phosphorylation of their receptors (Grigorescu et al., 1994; King et al., 1994; Maller, 1994) .
The level of p27 kip1 protein in mammalian cells is highest during G0 quiescence, where it blocks Cdk activity. Entry into G1 and subsequent cell cycle progression may be mediated by both an increased degradation of p27 kip1 by ubiquitin proteasome complex and translational regulation of p27 kip1 mRNA levels (Pagano et al., 1995; Hengst and Reed, 1996) . p27 kip1 has been shown to be a potent inhibitor of cyclin D/ Cdk4 and cyclin A/Cdk2 during G1 and G1/S transitions respectively (Poon et al., 1995) . Although p27 kip1 is highly abundant in G1, it is also present during the rest of the cell cycle. However, its function after S phase remains unclear. Recent studies have identi®ed the presence of an MPF inhibitor regulating G2/M transition in Xenopus (Lee and Kirschner, 1996) and homologs of p21 waf /p27 kip1 have been recently cloned from Xenopus (Su et al., 1995; Shou and Dunphy, 1996) . In this study we have used Xenopus oocytes for functional in vivo and in vitro analysis of puri®ed, recombinant human p27 kip1 protein and its role in regulation of cell cycle in this biological system.
Results

p27
kip1 blocks Xenopus laevis GVBD and its associated MPF kinase in vivo Injection of bacterially expressed, full-length p27 kip1 into Xenopus oocytes completely blocked meiotic maturation induced by either progesterone ( Figure  1a ) or insulin (Figure 1bb . To determine the molecular mechanism of the p27-induced GVBD blockade, we analysed MPF activity (measured as histone H1 kinase) in cleared lysate extracts obtained from separate batches of oocytes that had been kept in the presence of progesterone for 10 h and also injected with various amounts of full-length p27 kip1 or just control buer ( Figure 2a) . Treatment with the hormone alone resulted in meiotic maturation, which correlated with activation of the MPF kinase activity ( Figure 2a , lane 2). On the other hand, treatment with progesterone after injection with increasing concentrations of p27 kip1 ( Figure 2a , lanes 3 ± 5) allowed to observe a p27 kip1 -dependent blockade of the in vivo MPF activity. Thus, whereas 0.05 nM injected p27 kip1 did not inhibit MPF activation signi®cantly (Figure 2a , lane 5), concentrations of p27 kip1 one order of magnitude higher were able to fully inhibit the in vivo activation of MPF accompanying the GVBD process (Figure 2a , lanes 3 and 4). As a control, injection of p27 kip1 alone did not result in GVBD, nor activation of MPF in the injected oocytes ( Figure 2a, lane 1) .
To determine whether the injected p27 kip1 inhibited GVBD through blockade of activation of the pre-MPF kinase complex or through blockade of the kinase activity of an already hormonally activated Opposite effects of p27 kip1 C and p27 kip1 N on Xenopus cdc2 kinase J Font de Mora et al MPF kinase, we analysed the phosphorylation state of p34 cdc2 in the injected oocytes ( Figure 2b ). Activation of p34 cdc2 through dephosphorylation at the inhibitory sites Tyr15 and Thr14 can be detected in Western blots as a bandshift resulting in faster electrophoretic mobility. Hormonal treatment in the absence of injected p27 kip1 clearly produced such a bandshift (Figure 2b , compare lanes 3 and 4). The bandshift was totally absent in the p27-injected oocytes ( Figure  2b , lanes 1 and 2). Comparable results were obtained by using a phospho-speci®c (Tyr15) antibody which speci®cally detected the inactive, Tyr15-phosphorylated, p34 cdc2 form only in the p27-injected oocytes, as well as in the control oocytes kept in the absence of progesterone (Figure 2b , lanes 1 ± 3). Cdk2 and cdc2 show signi®cant homology in their primary structure at the amino terminus. Since this region of Cdk2 becomes displaced and disordered by p27 kip1 in the complex formed by both proteins (Russo et al., 1996) , it could be hypothesized that the injected p27 kip1 may cause a similar hindrance of dephosphorylation and subsequent activation of p34 cdc2 in the oocytes. We obtained further con®rmation that the injected p27 kip1 caused a blockade of the pathway leading to activation of pre-MPF and subsequent GVBD by analysing de novo synthesis of Mos protein, an event necessary for MPF activation and GVBD induction by progesterone. In contrast to control, progesteronetreated oocytes injected with buer alone, which showed clear synthesis of p39 Mos protein, the oocytes injected with p27 kip1 did not contain any detectable, newly synthesized Mos protein (not shown).
Taken together, these data indicate that bacterially expressed p27 kip1 interacts functionally with endogenous p34 cdc2 from Xenopus, producing a block of the hormone-dependent activation of MPF (a p34 cdc2 / cyclin B complex).
Direct physical and functional interaction between p27 kip1 and p34 cdc2 kinase
We further investigated the interaction between bacterially expressed p27 kip1 and the endogenous Xenopus p34 cdc2 by immunoprecipitating these two proteins from lysates of immature and progesteronematured oocytes previously incubated with puri®ed, recombinant p27 kip1 protein (Figure 3 ). Direct immunoblotting of mature and immature oocyte extracts with anti-p34 cdc2 allowed easy detection of the endogenous p34 cdc2 protein (Figure 3a , lanes 4 and 5). Lane 3 in vivo. (a) p27 kip1 inhibits histone H1 kinase activity in vivo. Oocytes injected with the indicated amounts of p27 protein (+) or with buer alone (7) were lysed after 12 h incubation in the presence (+) or absence (7) of 15 mM progesterone and clari®ed extracts were used for determining MPF activity using histone H1 as a substrate of phosphorylation (see Materials and methods). Final concentration of injected p27 protein inside the oocyte was estimated considering an average 1 mm diameter per oocyte. Results presented in this ®gure are representative of four separate, independent experiments. (b) p27 kip1 blocks p34 cdc2 activation in vivo. Oocytes injected with 5.5 mM recombinant p27 (lanes 1 and 2) were allowed to recover for 2 h before treatment with 15 mM progesterone for 5 h (+) or no treatment at all (7). Control oocytes were injected with the same volume of buer and treated the same way (lanes 3 and 4). 10 mg of clari®ed extracts were resolved in a 10 ± 20% SDS ± PAGE and immunoblotted (WB) with anti-p34 cdc2 antibody or with phospho-speci®c cdc2 (Tyr15) antibody that speci®cally detects cdc2 only when it is catalytically inactivated by phosphorylation at Tyr15 p27N inhibits, but p27C stimulates, hormone-induced GVBD and associated MPF kinase activity in vivo A common structural feature shared by the Cdk regulators p27 kip1 and p21 waf is a molecular structure where the amino terminal region contains the Cdkbinding domain and the carboxy terminal region encompasses a putative nuclear bipartite localization signal (Polyak et al., 1994b; Toyoshima and Hunter, 1994) . To study the functional properties of the aminoand carboxy-terminal regions of p27 kip1 in comparison with the full-length p27 kip1 molecule, these two regions were expressed in bacteria (amino acids 1 ± 100, designated p27N; amino acids 101 ± 198, designated p27C), puri®ed, and injected into Xenopus oocytes (Figure 4) .
Injection of p27N signi®cantly inhibited GVBD induced by progesterone ( Figure 4a ) and insulin (Figure 4b ), whereas it had no eect when injected into non-stimulated, immature oocytes (Figure 4c ). The inhibition mediated by p27N was not as severe as that produced by full-length p27 kip1 (which blocked completely hormone-induced maturation, see Figure 1 ), but consistently resulted in a 5 ± 7 h delay of T GVBD 50 (time at which 50% of the injected oocytes had undergone meiotic maturation) as compared to uninjected oocytes (Figure 4a and b) . In sharp contrast, p27C-injected oocytes consistently displayed accelerated rates of maturation in response to progesterone or insulin (Figure 4a and b) . Furthermore, injection of p27C alone into oocytes which received no subsequent Ten hours after start of progesterone treatment, injected oocytes were lysed and clari®ed extracts were used to determine the histone H1 kinase activity as described in Materials and methods (d).
Comparable observations were made in six independent experiments
Opposite effects of p27 kip1 C and p27 kip1 N on Xenopus cdc2 kinase J Font de Mora et al hormonal stimulation induced maturation, although with somewhat delayed kinetics (about 20 h delay in T GVBD 50 in comparison to hormones, see Figure 4c ), suggesting that the carboxy-terminal portion of p27 contains a weak maturation promoting activity. The eect of p27C and p27N on MPF kinase activity was also examined by measuring histone H1 kinase (Figure 4d ) in extracts of oocytes treated with progesterone for 10 h after injection of the designated recombinant protein preparation. At that time of incubation, maturation of p27-injected oocytes was normally completely blocked (Figure 1a) , whereas p27N-injected oocytes were starting to undergo GVBD, and the p27C-injected ones were already completely matured (Figure 4a) . Levels of MPF kinase activity (using histone H1 as a substrate) correlated closely with the kinetics of maturation and the %GVBD observed in each case. These observations suggest that, as for fulllength p27 kip1 , p27N and p27C exert their respective inhibitory and stimulatory eects directly on the p34 cdc2 component of MPF kinase in the injected oocytes. , p27N and p27C recombinant proteins on histone H1 kinase activity of hormone-matured oocyte lysates. 5 ml clari®ed extracts from progesterone-matured oocytes (12 h treatment) were assayed for their ability to phosphorylate histone H1 in the presence of 3 mM p27 kip1 , 3 mM p27N, 6 mM p27C or a combination of the above as indicated. Equimolar concentrations of p27C and p27 or p27N were also assayed giving similar results (data not shown). cdc2 or anti-p27C antibodies. 0.5 mg recombinant p27C was exogenously added to 100 mg of each of the mature and immature extracts, and immunoprecipitated (IP) with anti-p27 (C19) antibody. Immunoprecipitated material (IPP; lanes 3 and 4) and the supernatant after the immunoprecipitation (Sup.; lanes 5 and 6) were also immunoblotted with anti-p34 cdc2 or with antip27C (C19) antibodies as indicated. (b) 5 mg recombinant p27C were added to 100 mg of total lysate (30 ml ®nal total volume) from immature (lanes 1 and 4) and mature (lanes 2 and 5) oocytes, and 5 ml of the mixture was immediately assayed for histone H1 kinase activity (lanes 1 and 2) . The remaining mixture was diluted 1/20 and further immunoprecipitated with anti-p27C antibody and the immunoprecipitated material (IP) was assayed for histone H1 kinase activity (lanes 4 and 5). This ®gure is representative of three independent experiments. (c) 50 ml of p13 SUCI -agarose beads (v/v; Upstate Biotechnology Incorporated) were added to 100 mg of total lysates from immature oocytes. After 2 h of incubation at 48C, the agarose beads were extensively washed and equally split in four aliquots. Two of them were resolved by 10% SDS ± PAGE and immunoblotted with antip34 cdc2 antibody. The remaining two aliquots were assayed for histone H1 kinase in the absence (lane 1) or presence (lane 2) of 1 mg of exogenously added recombinant p27C
Opposite effects of p27 kip1 C and p27 kip1 N on Xenopus cdc2 kinase J Font de Mora et al added these exogenous, puri®ed proteins to cleared lysates of progesterone-matured oocytes and subsequently examined their eect on the histone H1 kinase activity present in such extracts. Consistent with the observed in vivo inhibitory eects (see Figures 1 and  2) , incubation with full length p27 kip1 completely inhibited the ability of active MPF to phosphorylate histone H1 (Figure 5, compare lanes 1 and 2) . Interestingly, p27N inhibited the histone H1 kinase activity of the lysate extracts to a similar extent than full-length p27 kip1 ( Figure 5, lane 3) . These results suggest that the amino-terminal portion of p27 kip1 , containing the binding site for Cdks (Polyak et al., 1994b; Toyoshima and Hunter, 1994) , is sucient for inhibition of MPF activity.
Consistent with in vivo observations (Figure 4d ), the carboxy-terminal region of p27 failed to block MPF activity in vitro and thus, histone H1 was phosphorylated (Figure 5a, lane 4) . Strikingly, we observed that exogenous p27C was phosphorylated after incubation with the MPF-containing extracts (Figure 5a, lane 4) . In contrast, full-length p27 kip1 incubated under similar conditions was not phosphorylated ( Figure 5a , lane 2). Finally, upon simultaneous addition of full-length p27 kip1 and p27C, the inhibitory eect of p27 kip1 was dominant over the eect observed with p27C alone (Figure 5a , lane 6). Likewise, simultaneous incubation of p27N and p27C with active lysates also inhibited the histone H1 kinase activity, as well as phosphorylation of the carboxy-terminus (Figure 5a , lane 5). Similar results (not shown) were obtained when, instead of using cleared lysates, the H1 kinase assays were performed on anti-p34 cdc2 immunoprecipitates of the same lysates.
Quantitative assays using increasing concentrations (expanding over four orders of magnitude) of each of the three recombinant p27 derivatives (Figure 5b ) revealed that both full-length p27 kip1 and p27N inhibit MPF activity in a dose-dependent manner (Figure 5b,  p27, p27N ). These assays also con®rmed that p27C fails to block MPF activity and becomes phosphorylated during the incubation with lysates (Figure 5b,  p27C) . The comparable inhibitory eect of p27 kip1 and p27N supports our previous suggestion that the Cdk binding site contained within p27N may account for the MPF blockade produced by full-length p27 kip1 .
p27C associates physically with and activates p34 cdc2
The positive eect of p27C on MPF activation and GVBD induction (Figure 4 ) could be explained by two dierent mechanisms. In one, (i) p27C could interact with the machinery that regulates MPF activation (i.e., cdc25 phosphatase, etc.) or otherwise (ii) it could directly complex with MPF itself. To distinguish between those two possibilities, we exogenously added p27C to lysates from mature and immature oocytes, and subjected them to immunoprecipitation with antip27C antibody. The immunoprecipitated material was then analysed by Western blotting with anti-p34 cdc2 and anti-p27C antibodies. The results shown in Figure 6a clearly demonstrated that p27C was able to complex with MPF from both mature and immature oocytes. Moreover, the immunocomplexes containing p27C and p34 cdc2 retained enzymatic histone H1 kinase activity (Figure 6b ; note how the immunoprecipitated material Immature oocytes Mature oocytes Figure 7 p27C induces histone H1 kinase activity and prevents its inactivation in Xenopus oocyte lysates. 5 ml clari®ed extracts from immature oocytes (lanes 1 ± 6) or progesterone-matured oocytes (lanes 7 ± 11) were preincubated for the indicated times at 48C with 1 mg p27C (+) or with an equivalent volume of buer (7) (20 mM Tris/HCl, pH 7.4). After the preincubation, all mixture samples were further incubated for 20 min at room temperature in the presence of histone H1 (see Materials and methods) to determine the resulting MPF kinase activity. This data is supported by results from three separate experiments Opposite effects of p27 kip1 C and p27 kip1 N on Xenopus cdc2 kinase J Font de Mora et al concentrated the kinase activity present in total lysates: compare intensities of lanes 4 and 5 with those of lanes 1 and 2). These data also suggest that addition of p27C to non mature oocyte lysates induces MPF activation (Figure 6b, lanes 1 and 4) . To further con®rm that isolated p27C is able to activate the p34 cdc2 kinase, we took advantage of the ability of p13 SUC1 -agarose conjugated beads to bind and isolate the non active MPF from immature oocyte lysates (Marcote et al., 1993; Patra and Dunphy, 1996; Samiei et al., 1991) . Western blot analysis of the complex retained in the beads demonstrated the presence of p34 cdc2 (upper panel, Figure 6c ). Addition of p27C to this complex resulted in a signi®cant induction of the histone H1 kinase activity (lane 2 in lower panel), in contrast to control in which an equal volume of buer alone was added (lane 1, lower panel). Addition of full-length p27 kip1 did not induce the kinase activity, as expected (data not shown). These results strongly suggest that p27C is responsible for the direct activation of the MPF kinase activity.
p27 activates in vitro MPF in lysates of immature Xenopus oocytes and stabilizes active MPF in lysates of mature oocytes
In contrast to p27 kip1 and p27N, which block in vitro the MPF kinase activity in extracts of hormonematured oocytes (Figure 5 ), we observed that addition of p27C to lysates of immature oocytes resulted in activation of the MPF kinase, as determined by assays of histone H1 phosphorylation (Figure 7) . Moreover, incubation of the exogenous p27C with the extracts of immature oocytes for as short a period of time as the duration of the H1 kinase assay (*20 min) was enough to result in detectable activation of the H1 kinase activity (0 h preincubation, Figure 7 , lane 2), which was absent from the same lysate incubated alone (lane 1). Preincubation of the lysates with p27C at 48C for various periods of time prior to the H1 kinase assay produced even higher increases of activation of the MPF kinase. Detailed time course experiments (not shown) demonstrated that the increase in MPF activity was maximal at 8 h of preincubation (compare lane 3 to control lane 4 in Figure 7 ). Longer incubation times resulted in decreased levels of activation (compare lanes 5 and 6, corresponding to 18 h of incubation in the absence and presence of p27C, respectively).
Similar incubations of p27C with extracts of mature oocytes (where MPF kinase was already active, see lane 7) uncovered a further ability of the p27C protein to stabilize this kinase activity of an already activated MPF (Figure 7, lanes 8 ± 11) . Thus, whereas incubation of the mature lysate extracts alone for 8 and 18 h resulted in practically undetectable levels of H1 kinase activity (Figure 7, lanes 8 and 10) , similar incubation times in the presence of added p27C resulted in a clear preservation of the H1 kinase activity (Figure 7, lanes 9  and 11) .
The enzymatic activity of MPF normally decreases after GVBD, as a consequence of cyclin B degradation (Kobayashi et al., 1994) . Our results strongly suggest that the C-terminal portion of p27 kip1 encompasses a domain(s) which is able not only to activate but also to stabilize the kinase activity of the p34 cdc2 /cyclin complex. Since it is likely that phosphatase or protease activities mediate the usual loss of enzymatic activity, an interesting hypothesis is that the p27C molecule forms a ternary complex with the activated p34 cdc2 / cyclin B complex and this association could be responsible for the in vivo and in vitro activation of the MPF kinase observed. Such a functional role would be similar to that of the CAK subunit MAT1p36, which promotes the assembly and stabilization of cdk7/cyclinH complexes (Devault et al., 1995; Tassan et al, 1995) . p27C enhances the in vitro kinase activity of puri®ed human p34 cdc2 /cyclin B complex
All previous results have been obtained in the context of the Xenopus oocytes. In this system, in vivo microinjection experiments as well as kinase assays performed with total lysates or dierent immunocomplexes revealed the activation of p34 cdc2 by p27C. To further demonstrate such a direct activation, we used the puri®ed p34 cdc2 /cyclin B enzyme from baculovirus infected sf9 cells (New England BioLabs) for in vitro experiments. We demonstrated that addition of p27C to the active, isolated complex, enhanced the histone H1 kinase activity in a dose dependent manner (Figure  8 ), con®rming the direct activation of p34 cdc2 by p27C.
Evidence for a p27C-like fragment in murine cells
In an eort to ascertain the physiological relevance, if any, of p27C, we analysed NIH3T3 cells for the potential in vivo existence of truncated fragments of p27 kip1 which might be functionally similar to the recombinant p27C analysed here in Xenopus oocytes. As shown in Figure 9 , in cycle-arrested NIH3T3 cells stimulated with PDGFbb, the full-length p27 kip1 is rather abundant at the early G1 stage of cell cycle, and decreases progressively with cell cycle progession. In addition, the decrease of full-length p27 kip1 was coupled with the accumulation of a faster migrating band (about 20 kDa; recognized by the anti-p27C antibodies), that appeared concomitantly with expression of cyclin A, used as a marker of G2 phase of the cell cycle. The p27C antibody used here speci®cally recognizes amino acids 181 ± 198, mapping at the carboxy-terminus of human p27 kip1 and does not cross-react with p21
Waf . In contrast, this 20 kDa fragment was not detected with an antibody raised against the amino-terminus of p27 kip1 (p27 N-20, Santa Cruz Biotech.), whereas the full-length p27 kip1 was equally detected (data not shown).
Discussion
Mammalian p27
kip1 functions in G2/M progression of Xenopus oocytes through direct interaction with p34 cdc2 kinase We observed that injection of human p27 kip1 into Xenopus oocytes produced a dose-dependent, speci®c, blockade of meiotic maturation and its associated MPF kinase activation induced by both progesterone and insulin. Since (i) p27 kip1 is a known inhibitor of Cdks and (ii) insulin and progesterone activate dierent signalling pathways that eventually result in Opposite effects of p27 kip1 C and p27 kip1 N on Xenopus cdc2 kinase J Font de Mora et al MPF activation (Grigorescu et al., 1994; King et al., 1994; Maller, 1994) , the observed ability to block progesterone-and insulin-induced GVBD suggested that p27 kip1 might be acting at the level of the MPF (cyclin B/p34 cdc2 ) complex activation. Indeed, using speci®c antibodies we were able to demonstrate that the exogenously injected p27 kip1 interacts directly with the endogenous oocytes p34 cdc2 . Such interaction occurred preferentially in mature oocytes (where the complex cyclin B/p34 cdc2 is very abundant), although it was also detectable, at much lower extent, in immature oocytes (where monomeric p34 cdc2 is in a tenfold excess of the cyclin complex; Gautier and Maller, 1991) . These observations are consistent with the known preferential participation of p27 kip1 in ternary complexes with cyclins and kinases (Aprelikova et al., 1995; Hall et al., 1995) .
Our results showed that, in addition to being able to block in vivo and in vitro activation of MPF, the exogenous p27 kip1 could also block the enzymatic activity of already active MPF from mature oocytes. These results are consistent with the reported association of p27 kip1 with cyclin D/Cdk4 that prevents Cdkactivating kinase (CAK) from phosphorylating and activating the complex (Kato et al., 1994) and also blocks in vitro phosphorylation of Cdk2 (Aprelikova et al., 1995) . Moreover, crystal structure analysis indicates that the interaction of p27 kip1 inhibitory domain (p27N) with cyclin A/Cdk2 blocks its activity by inserting into the catalytic cleft mimicking ATP and also causes rearrangements at the amino-terminal lobe, where dephosphorylation must occur to become an active complex (Russo et al., 1996) . Since p34 cdc2 has an identical dephosphorylation pattern than Cdk2, a similar rearrangement could be predicted here. Our results (Figure 2b ) indicate that p27 kip1 also inhibits the activation of p34 cdc2 , probably due to the disorder caused at the p34 cdc2 amino-terminal lobe (amino acids 1 ± 13) located next to phosphorylation sites Thr14 and Tyr15.
The results observed with exogenous human p27 kip1 injected into oocytes may also be relevant for the characterization of physiological mechanisms regulating endogenous cdc2 kinase activity in oocytes. Recent reports have described the identi®cation of Xenopus Cdk inhibitors highly equivalent to mammalian p27 kip1 (p27 xic1 , Su et al., 1995; p28 kix1 , Shou and Dunphy, 1996) . Similarly to p21 waf , they both possess C-terminal PCNA binding sites which display varying binding eciency. However, no activity/function for p27 kip1 Cterminus has yet been reported.
Opposite functional eects of the N-and C-terminal domains of p27 kip1
The similarity between the N-terminal regions of p27 kip1 and p21 waf is consistent with their common ability to inhibit cyclin/Cdk kinase activity. The crystal structure of the amino-terminal half of p27 forming complex with cyclin A/Cdk2 has revealed the interactions occurring in this heterotrimeric complex, explaining the mechanism by which p27N blocks the kinase activity (Russo et al., 1996) . Transient transfection of p27 or p27N inhibit DNA synthesis and cell cycle progression, though p27C did not show any inhibitory eect (Luo et al., 1995) . Consistent with those reports in mammalian cells, we observed in Xenopus oocytes that the N-terminal half of p27 kip1 (p27N) perfectly mimicked full-length p27 in its ability to block oocyte maturation, activation of MPF, and MPF kinase enzymatic activity. However, p27N blockade of oocyte maturation was not as potent as that caused by full-length p27 kip1 protein. One possible explanation is that p27N lacks the potential bipartite nuclear localization signal, present at the carboxy terminus of full-length p27 kip1 , that could contribute to a better redistribution within the oocyte. It is also possible that p27N does not completely match the ®nal structure of whole p27 that allows a more dramatic interaction and inhibitory eect in vivo. Another possibility could be the existence of an additional, still unidenti®ed region within p27C, but not in p27N, that somehow would stabilize or increase the inhibitory eect of p27N. Such a hypothetical region of p27C might also be involved in the interaction with the cyclin/Cdk complex, as reported for p27N (Russo et al., 1996) . This would be consistent with our data because, (i) only p27C alone (but not in combination with p27N), is able to induce activation of p34 cdc2 and (ii) p27C forms a complex with cyclin B/p34 cdc2 (it coimmunoprecipitates with p34 cdc2 and brings down its activity). We also showed that immunoprecipitation with anti-p27C antibodies from oocytes lysates supplemented with p27C protein brought down p34 cdc2 as well as its activity (Figure 6 ). On the other hand p13 SUCI -agarose complexes from immature oocytes (containing inactive p34 cdc2 ) became enzymatically active after the addition of p27C protein. Finally, we showed that the activity of the puri®ed p34 cdc2 / cyclin B complex was enhanced, in a dose dependent manner, by addition of p27C. Taking all together, this data strongly suggest that p27C activates or enhances p34 cdc2 activity through a direct interaction. MPF in vitro activation by p27C requires greater amounts of p27C than when directly injected into the oocytes. Maturation of oocytes injected with 5.6 pmoles of p27C occurs within 20 h, concomitantly with the activation of MPF (Figure 4) . In vitro experiments are performed with lysates of immature oocytes, where the MPF complex is inactive and no possible subcellular accumulation can occur. p27C is then added to these extracts and following a 20 min incubation we observe that MPF becomes activated. Therefore, given the potential dierences between this in vitro assay and the in vivo situation, the higher concentration of p27C is perhaps required in order to displace a critical component of the MPF complex during this short assay period. The potential mechanism for cyclin B functional participation in such a complex remains unclear.
In sharp contrast to the results observed with p27 or p27N, oocytes microinjected with p27C showed a signi®cant acceleration of the kinetics of GVBD induced by progesterone or insulin. Furthermore, p27C microinjected alone (in the absence of any hormonal treatment) was also able to induce GVBD and MPF activation with slow kinetics. Consistent with the in vivo results, we also demonstrated, using in vitro assays, that p27C was able to activate the MPF kinase in lysates of immature oocytes, and to prevent deactivation of active MPF from mature oocyte lysates.
The major structural dierences between p27 kip1 and p21
waf are found at their C-terminal half regions. They both have a potential nuclear bipartite localization sequence but p21 waf contains a PCNA binding domain not found in p27 kip1 . Furthermore, and perhaps relevant to our studies, p27 kip1 contains a unique potential phosphorylation site for p34 cdc2 at the carboxy terminus that may be physiologically relevant (Polyak et al., 1994b; Toyoshima and Hunter, 1994) . We have been unable to detect signi®cant phosphorylation of p27 kip1 during the cell cycle of murine ®broblasts (unpublished observations). In contrast, p27C proved to be at least an in vitro substrate for active MPF, since incubation of exogenously added p27C with lysates of mature oocytes resulted in detectable phosphorylation of this fragment. Such phosphorylation however, appears to be inconsequential for p27C activity in the oocytes, since mutant proteins encompassing the substitution T187D or the deletion D187 ± 198 induced oocyte GVBD at levels comparable to wildtype p27C (data not shown). Therefore, if phosphorylation at T187 occurs in vivo, it may play a dierent role than modi®cation of p27C activity. An interesting hypothesis is that phosphorylation of the p27C domain might mark the full-length protein for further processing or degradation.
The antagonistic eects of p27N and p27C was further substantiated in experiments analysing the phosphorylation undergone by p27C exogenously added to oocyte lysates from mature oocytes (containing active MPF kinase). Simultaneous addition of either full length p27 kip1 or p27N blocked the MPF kinase activity and therefore the phosphorylation of exogenously added substrates such as p27C (or histone H1). This observation, and the inhibitory eects produced by full length p27 kip1 (encompassing both p27N and p27C domains) suggested that the functional eects of the p27N domain may be dominant over those of p27C.
A potential role of p27C fragment in the cell cycle?
The striking eect of p27C in Xenopus oocytes (opposite from that of full length p27 kip1 and p27N), raised the question of whether a processed C-terminal portion of p27 kip1 , functionally similar to the p27C used here, might play a similar stimulatory role in vivo in regulation of the mammalian cell cycle.
It is known that p27 kip1 accumulates in early G1 phase (Hengst and Reed, 1996; Polyak et al., 1994a; Poon et al., 1995) , and that exit of the cell cycle at the G0 restriction point requires Cdk inhibition by p27 kip1 (Coats et al., 1996) . For example, the anti-mitogenic eect of 1,25-dihydroxyvitamin D 3 on HL60 cells results from a G1/S blockade mediated by p27 kip1 (Wang et al., 1996) . On the other hand, further progression through G1 requires activation of cyclin/ Cdk complexes (i.e., Cyclin D/Cdk4 and cyclin E/ Cdk2) and deactivation of Cdk inhibitors. In this regard, it has been reported that interleukin 2 (IL-2) mediates the elimination of p27 kip1 , thus allowing G1 to S progression (Nourse et al., 1994) . The cellular level of p27 kip1 is lower after G1 and appears to be regulated, at least in part, through the ubiquitin-proteasome pathway (Pagano et al., 1995) .
An interesting hypothesis is that proteolytic degradation of full length p27 kip1 might result in production and accumulation of a carboxy-terminal product, lacking the inhibitory eect of p27 kip1 (and p27N in our system) and displaying similar stimulatory eects to those observed for p27C in the oocytes. In agreement with such model, NF-kB is known to undergo limited proteolysis by the proteasome complex, thus giving rise to an active, truncated protein (Palembella et al., 1994) . In an eort to test this hypothesis, we have analysed lysates of synchronized NIH3T3 ®broblasts at dierent times during progression of the cell cycle by means of Western blot with antibodies to the N and C-terminal portion of p27 kip1 . A smaller fragment (about 20 kDa) accumulating concomitantly with cyclin A (highly abundant at the G2 stage of the cell cycle) was detected using an antip27C antibody. If this short C-terminal p27 kip1 product proves similar in structure/function to the bacteriallyexpressed p27C fragment used here; it will be interesting to test the possibility that it may play an in vivo physiological regulatory role in cell cycle progression, probably at the G2 phase when it becomes highly abundant and its progenitor (whole p27 kip1 ) is highly depleted.
Materials and methods
Protein expression and puri®cation
To investigate the role of p27 in cell cycle progression, we ampli®ed DNA corresponding to the entire coding region of human p27 kip1 , the amino acids 1 ± 100 (p27N) and amino acids 100 ± 198 (p27C). The PCR products were then cloned into the bacterial expression vector PQE30 (Qiagen) which contains a polyhistidine linker. The recombinant proteins were then expressed in M15 Escherichia coli cells harboring plasmid pREP4 (Qiagen) and puri®ed to homogeneity as described previously (Font de Mora et al., 1996) . We next examined the eect of p27 recombinant protein on G2/M cell cycle progression by microinjection into fully grown X. laevis oocytes.
Oocyte preparation and microinjection
Adult femlae Xenopus laevis were obtained from Xenopus I or Nasco and stimulated to ovulate by injecting 100 units of pregnant mare serum gonadotropin (Calbiochem) 3 days before oocyte extraction. Ovarian fragments were surgically removed from frogs anesthetized by hypothermia. Fully grown stage VI oocytes were manually dissected into ND-96 medium (5 mM HEPES, 96 mM NaCl, 1 mM MgCl 2 , 2 mM KCl, 1.8 mM CaCl 2 , pH 7.8 and 10 mg/ml each of penicillin and streptomycin sulfate). The oocytes were allowed to recover overnight in the same buer before further treatment and were always maintained at 208C.
For induction of meiotic maturation, groups of 10 ± 30 oocytes were incubated in ND-96 without KCl in the presence of progesterone (15 mM, Sigma) or insulin (7.5 mM, Sigma), or were microinjected with up to 60 nl per oocyte of puri®ed p27 kip1 proteins and then allowed to recover for 2 h before the hormonal treatment. Control oocytes were microinjected with buer alone. Meiotic maturation was assayed by scoring the disappearance of the nucleus (GVBD) in oocytes ®xed with 10% trichloroacetic acid. In most cases, the absence of the nucleus correlated with the appearance of a white spot in the animal pole.
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Preparation of oocyte lysates
Twelve hours after exposure to hormones, microinjected oocytes were homogenized in ice-cold buer (20 ml/oocyte) containing 20 mM HEPES, pH 7.4, 10 mM EGTA, 15 mM MgCl 2 , 1 mM dithiothreitol, 100 mM b-glycerophosphate, 2 mM sodium orthovanadate, 1 mM phenylmethylsulfonyluoride and 10 mg/ml aprotinin and leupeptin.
Protein kinase assays 5 ml of clari®ed extracts or the puri®ed p34 cdc2 /cyclin B enzyme (New England BioLabs) were incubated in a ®nal volume of 15 ml with 3 mg of exogenous histone (type II-S calf thymus; Sigma), 100 mM cold ATP and 4 mCi of [g-32 P]ATP (3000 Ci/mmol, Amersham Corp.) for 20 min, at room temperature. Phosphorylated histone H1 was visualized by autoradiography after SDS ± PAGE on 10 ± 20% gradient gels. In vitro assays were carried out by addition of 15 ml of the reaction buer to the immunocomplexes or to the p13 SUCI -agarose beads (Upstate Biotechnology Incorporated) bound material.
Immunoprecipitation and immunoblot analysis
Clari®ed oocyte extracts were immunoprecipitated with the indicated antibodies (anti-p27 (C-19) or anti-p34 cdc2 , Santa Cruz Biotech.) in the presence of GammaBind G Sepharose beads (Pharmacia) for 2 h at 48C, and the immune complexes were washed three times with lysis buer, once with LiCl 0.5 M in 100 mM Tris/HCl pH 7.5 and once more with lysis buer. Anti-p34 cdc2 immunoprecipitates were resuspended in 20 ml of the kinase reaction buer and used for histone H1 kinase activity experiments. Following SDS ± PAGE, the proteins were transferred to Immobilon-P membranes (Millipore), probed with the indicated antibodies and visualized by ECL (Amersham). Phosphospeci®c cdc2 (Tyr15) antibody (New England Biolabs) was used to speci®cally immunodetect the inactive form of p34 cdc2 phosphorylated on Tyr15.
